Incentivi ai farmaci generici a livello di ASL: l’osservatorio I.H.A.G.O.

Generic drugs are pharmaceutical products that contain an active substance whose patent-covered period expired and are marketed with the name of the molecule. The public health authorities of most EU countries agree on the importance of generic drugs in rationalising the pharmaceutical market, parti...

Full description

Bibliographic Details
Main Authors: Silvia Martina, Dante Cornago, Livio Garattini, I.H.A.G.O Gruppo di studio I.H.A.G.O
Format: Article
Language:English
Published: SEEd Medical Publishers 2002-06-01
Series:Farmeconomia: Health Economics and Therapeutic Pathways
Online Access:https://journals.seedmedicalpublishers.com/index.php/FE/article/view/746